Your browser doesn't support javascript.
loading
Diagnostic criteria for apathy in neurocognitive disorders.
Miller, David S; Robert, Philippe; Ereshefsky, Larry; Adler, Lawrence; Bateman, Daniel; Cummings, Jeff; DeKosky, Steven T; Fischer, Corinne E; Husain, Masud; Ismail, Zahinoor; Jaeger, Judith; Lerner, Alan J; Li, Abby; Lyketsos, Constantine G; Manera, Valeria; Mintzer, Jacobo; Moebius, Hans J; Mortby, Moyra; Meulien, Didier; Pollentier, Stephane; Porsteinsson, Anton; Rasmussen, Jill; Rosenberg, Paul B; Ruthirakuhan, Myuri T; Sano, Mary; Zucchero Sarracini, Carla; Lanctôt, Krista L.
Affiliation
  • Miller DS; Signant Health, Blue Bell, Pennsylvania, USA.
  • Robert P; Cognition Behaviour Technology Lab, Université Côte d'Azur, Nice, France.
  • Ereshefsky L; Association Innovation Alzheimer, Nice, France.
  • Adler L; Centre Memoire, Centre Hospitalier Universitaire de Nice, Nice, France.
  • Bateman D; Follow the Molecule, Marina del Rey, California, USA.
  • Cummings J; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • DeKosky ST; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Fischer CE; Department of Brain Health, School of Integrated Health Sciences, University of Nevada, Las Vegas, Nevada, USA.
  • Husain M; Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA.
  • Ismail Z; Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
  • Jaeger J; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Lerner AJ; Keenan Research Centre for Biomedical Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Li A; Department of Experimental Psychology, University of Oxford, Oxford, UK.
  • Lyketsos CG; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Manera V; Oxford NIHR Biomedical Research Centre, Oxford, UK.
  • Mintzer J; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Moebius HJ; CognitionMetrics, Wilmington, Delaware, USA.
  • Mortby M; University Hospitals - Case Western Reserve University, Cleveland, Ohio, USA.
  • Meulien D; Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Pollentier S; Johns Hopkins University, Baltimore, Maryland, USA.
  • Porsteinsson A; Cognition Behaviour Technology Lab, Université Côte d'Azur, Nice, France.
  • Rasmussen J; Association Innovation Alzheimer, Nice, France.
  • Rosenberg PB; Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA.
  • Ruthirakuhan MT; Moebius-Consult, Baar, Switzerland.
  • Sano M; UNSW Ageing Futures Institute, The University of New South Wales, Sydney, Australia.
  • Zucchero Sarracini C; Clinical Research and Development, H. Lundbeck A/S, Valby, Denmark.
  • Lanctôt KL; Boehringer Ingelheim Pharma GmbH & Co KG, CNS Diseases Research, Biberach an der Riss, Germany.
Alzheimers Dement ; 17(12): 1892-1904, 2021 12.
Article in En | MEDLINE | ID: mdl-33949763
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Delphi Technique / Neurocognitive Disorders / Consensus / Expert Testimony / Apathy Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: Alzheimers Dement Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Delphi Technique / Neurocognitive Disorders / Consensus / Expert Testimony / Apathy Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: Alzheimers Dement Year: 2021 Type: Article Affiliation country: United States